Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Sebocytes play a key role in controlling androgen levels in human skin.

The enzyme system in hair follicles is similar to the liver's and is inhibited by certain substances.

Diphlorethohydroxycarmalol may help treat hair loss better than current medications.

Suppressing very long chain fatty acids is linked to skin cancer.

Adrenomedullin 2 stops cell growth and causes cell death in human hair follicles.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

New progesterone-based compounds can block male hormones.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Serotonin helps wounds heal faster.

The ACTH/MC2R system is crucial for controlling hair growth cycles in mice.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Blocking mTORC1 reduces skin tumor growth in mice.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Finasteride slowly binds to 5-alpha-reductase, affecting enzyme stability and inhibitor potency.

Increasing miR-149 reduces hair follicle stem cell growth and hair development by affecting certain cell growth pathways.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.